Existing methods of engineering one of the most commonly used gene-delivery vehicles, adeno-associated viruses (AAV), are ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

AAVs are widely accepted vehicles to deliver gene therapies ... great confidence to increase our investment in therapeutic gene delivery, to support our neurological disease portfolio,” Roche ...

Unlike virus-based gene therapies, the dosing of enGene’s nonviral delivery vehicle is transient, owing to the rapid turnover of epithelial cells in mucosal tissues. It is also repeatable ...

AAVs have become the therapeutic gene delivery vehicle of choice because they are non-pathogenic, easy to produce, transduce efficiently across various cell types, and show low immunogenicity.

Aptamer's Optimer technology achieves key milestones in genetic medicine delivery, enhancing targeting specificity and ...

The gene's name is derived from Tír na ... They then used a special delivery system—called a polymeric vehicle—to deliver a common antibiotic (doxycycline) directly to the damaged muscle ...